Literature DB >> 12384393

Lopinavir measurement in pleural effusion in a human immunodeficiency virus type 1-infected patient with kaposi's sarcoma.

Marta Boffito, Patrick G Hoggard, David J Back, Stefano Bonora, Agostino Maiello, Anna Lucchini, Giovanni Di Perri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12384393      PMCID： PMC128730          DOI： 10.1128/AAC.46.11.3684-3685.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  11 in total

Review 1.  Antiretroviral drugs and the central nervous system.

Authors:  R H Enting; R M Hoetelmans; J M Lange; D M Burger; J H Beijnen; P Portegies
Journal:  AIDS       Date:  1998-10-22       Impact factor: 4.177

2.  Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir.

Authors:  G Pialoux; S Fournier; A Moulignier; J D Poveda; F Clavel; B Dupont
Journal:  AIDS       Date:  1997-08       Impact factor: 4.177

3.  Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood.

Authors:  R W Coombs; C E Speck; J P Hughes; W Lee; R Sampoleo; S O Ross; J Dragavon; G Peterson; T M Hooton; A C Collier; L Corey; L Koutsky; J N Krieger
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

4.  Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity.

Authors:  Kalonji R Collins; Miguel E Quiñones-Mateu; Mianda Wu; Henry Luzze; John L Johnson; Christina Hirsch; Zahra Toossi; Eric J Arts
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1.

Authors:  M Poss; A G Rodrigo; J J Gosink; G H Learn; D de Vange Panteleeff; H L Martin; J Bwayo; J K Kreiss; J Overbaugh
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir.

Authors:  R M van Praag; G J Weverling; P Portegies; S Jurriaans; X J Zhou; M L Turner-Foisy; J P Sommadossi; D M Burger; J M Lange; R M Hoetelmans; J M Prins
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

7.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

8.  Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir.

Authors:  S Taylor; D J Back; S M Drake; J Workman; H Reynolds; S E Gibbons; D J White; D Pillay
Journal:  J Antimicrob Chemother       Date:  2001-09       Impact factor: 5.790

9.  Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissues of an AIDS patient.

Authors:  M Ait-Khaled; J E McLaughlin; M A Johnson; V C Emery
Journal:  AIDS       Date:  1995-07       Impact factor: 4.177

10.  Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences.

Authors:  B T Korber; K J Kunstman; B K Patterson; M Furtado; M M McEvilly; R Levy; S M Wolinsky
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103
View more
  2 in total

1.  Population pharmacokinetics of lopinavir predict suboptimal therapeutic concentrations in treatment-experienced human immunodeficiency virus-infected children.

Authors:  Natella Rakhmanina; John van den Anker; Aline Baghdassarian; Steven Soldin; Keetra Williams; Michael N Neely
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

Review 2.  Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.

Authors:  Nicolas Venisse; Gilles Peytavin; Stephane Bouchet; Marie-Claude Gagnieu; Rodolphe Garraffo; Romain Guilhaumou; Caroline Solas
Journal:  Antiviral Res       Date:  2020-07-10       Impact factor: 5.970
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.